Showing results (491-500 of 559) with videos related to

Sort By:
Pageof 56
Blood|January 3, 2012
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphomaRobert Kridel, Barbara Meissner, Sanja Rogic, et al.
Blood|August 12, 2024
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2Brett Collinge, Susana Ben-Neriah, Laura K Hilton, et al.
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2018
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in miceYing Wang, Lijing Su, Matthew D Morin, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Genome Biology|February 28, 2015
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsEmilia L Lim, Diane L Trinh, David W Scott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trialsTorsten Holm Nielsen, Zuanel Diaz, Rosa Christodoulopoulos, et al.
Biotechniques|February 13, 2019
A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral bloodPawan K Pandoh, Richard D Corbett, Helen McDonald, et al.
Blood|December 31, 2010
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylationDamian B Yap, Justin Chu, Tobias Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastomaOlena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
Pageof 56